| Produktinformation |
Auf dieser Seite finden Sie alle Nachrichten zeitlich geordnet und zu unterschiedlichen Themen der letzten drei Tage aufgelistet. Wählen Sie aus der untenstehenden Tabelle die für Sie interessante Nachricht aus. Zusätzlich können Sie auch unsere Nachrichtensuche nutzen, um damit noch detaillierter nach bestimmten und weiter zurückliegenden Nachrichten zu suchen.
| 06.01.2026 09:00 Original-Research: Borussia Dortmund GmbH & Co KGaA (von NuWays AG): BUY ^
Original-Research: Borussia Dortmund GmbH & Co KGaA - from NuWays AG
06.01.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS
Group.
The issuer is solely responsible for the content of this research. The
result of this research does not constitute investment advice or an
invitation to conclude certain stock exchange transactions.
---------------------------------------------------------------------------
Classification of NuWays AG to Borussia Dortmund GmbH & Co KGaA
Company Name: Borussia Dortmund GmbH & Co KGaA
ISIN: DE0005493092
Reason for the research: Update
Recommendation: BUY
Target price: EUR 5.2
Target price on sight of: 12 months
Last rating change:
Analyst: Philipp Sennewald
Normalization following 2 volatile seasons; chg.
Following a mixed 2024/25 season, which was highlighted by reaching the UCL
quarterfinals but also showed sluggish performances in the Bundesliga, where
BVB only reached the top-4 thanks to an impressive recovery run towards the
end of the seasons, the club looks now set for a normalized campaign.
After a solid performance in the first 15 Bundesliga games, BVB entered the
winter-break in 2nd place, being 5 points clear of 5th placed Hoffenheim.
Despite being 2nd, winning the Bundesliga is not in the cards in our view,
given the dominant performance of Bayern Munich thus far (3.3% probability
according to betting providers), which is why the focus should be on
finishing in the top-4 (95% probability) - the current hurdle to achieve UCL
qualificaftion.
In contrast, BVB's domestic cup campaign ended earlier than expected (eNuW:
quarterfinals), with the team being eliminated in the round of 16. As a
result, prize money from this competition will be lower than anticipated,
which is why we slightly adjust our forecast (EUR 1.7m direct top-line
effect).
A similar picture can be observed in the UCL, where BVB sits 10th after 6
games and is already qualified for the knockout stage of the competition.
With two matches remaining in the league phase (Tottenham away & Inter Milan
at home), BVB still has a 26.2% chance of finishing in the top-8 (according
to an Opta simulation) and thereby avoiding the play-off round. Given the
strength of the remaining opponents, we forecast BVB to finish in the low
teens, which should result in a beatable opponent in the play-off round
(seeded format) and allow them to reach the round of 16. That said, we
currently do not expect the team to advance beyond this stage, leaving some
upside to our model (quarterfinal prize money: EUR 12.5m). Overall, we
estimate UCL prize/TV money of EUR 78m for the 2025/26 season.
Based on the athletic performance of the squad as well as new sponsoring
contracts (i.e. Vodafone, Puma, Polestar, Rewe), FY25/26e sales are seen to
come in at EUR 507m (-3.7% yoy). The yoy decline is mainly attributable to the
one-off impact of the FIFA Club World Cup, which took place in the US during
the summer and was largely recognised in FY24/25 (EUR 33.9m; FY25/26e: EUR 13m),
as well as the team's run to the UCL quarterfinals in the prior season.
Despite that, we expect an EBITDA improvement to EUR 135m (26.6% margin)
driven by improved net transfer income (EUR 52.9m in Q1 25/26 vs 37.8m in
FY24/25) following Jamie Gittens transfer to Chelsea.
Action. Minor FY25/26e forecast changes reflect earlier than expected
domestic cup exit.
That being said, shares continue to trade at an undemanding 0.8x EV/Sales
FY25/26e (vs 2.1x peer group median). We hence reiterate BUY with an
unchanged PT of EUR 5.20 based on DCF.
You can download the research here:
https://eqs-cockpit.com/c/fncls.ssp?u=d0181557de2482811c46ef7e1c2aedb0
For additional information visit our website:
https://www.nuways-ag.com/research-feed
Contact for questions:
NuWays AG - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss
bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben
analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++
---------------------------------------------------------------------------
The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
View original content:
https://eqs-news.com/?origin_id=c3f68cd6-eacd-11f0-be29-0694d9af22cf&lang=en
---------------------------------------------------------------------------
2255044 06.01.2026 CET/CEST
°Weitere Nachrichten |
| Name | Kurs | Währung | Datum | Zeit | Handelsplatz |
|---|---|---|---|---|---|
| BORUSSIA DORTMUND GM... | 3,310 | EUR | 07.01.26 | 17:35 | Xetra |
|
| Lesen Sie auch weitere interessante Nachrichten u.a. zu den Themen Aktien im Fokus, Hintergrundberichte, Börsentag auf einem Blick, Wochenausblick oder adhoc-Mitteilungen. |
|
07.01.2026 LEXSTON LIFE SCIENCES CORP. Geschäftsbericht DAISEKI Geschäftsbericht PRICESMART Geschäftsbericht CONSTELLATION BRANDS INC. Geschäftsbericht Übersicht |